Drug intelligence / Profile preview

Pancreatic polypeptide

Development stage
Phase 4
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Intravenous, Subcutaneous
01

Overview

Pancreatic polypeptide is a 36-amino-acid peptide hormone secreted by the PP (F) cells of the endocrine pancreas. It acts primarily as an agonist at Neuropeptide Y receptor Y4. Pancreatic polypeptide regulates both endocrine and exocrine pancreatic secretion, modulates digestion by inhibiting gastric emptying and biliary secretion, and affects hepatic glycogen levels and gastrointestinal secretions. Its secretion increases after protein meals, fasting, exercise, or hypoglycemia. Peripheral administration of pancreatic polypeptide has been shown to decrease appetite and food intake in humans and rodents[1][3][4][6]. The exact physiological role in healthy individuals is not fully defined but includes modulation of digestive processes and energy homeostasis[1][3]. It has been investigated for potential therapeutic use in conditions such as type 1 diabetes mellitus[2].

Other names
PP
02

Targets

NPY4R (Neuropeptide Y receptor Y4)

Beyond the preview

Go deeper on Pancreatic polypeptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pancreatic polypeptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call